Cargando…
Protein markers and risk of type 2 diabetes and prediabetes: a targeted proteomics approach in the KORA F4/FF4 study
The objective of the present study was to identify proteins that contribute to pathophysiology and allow prediction of incident type 2 diabetes or incident prediabetes. We quantified 14 candidate proteins using targeted mass spectrometry in plasma samples of the prospective, population-based German...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6451724/ https://www.ncbi.nlm.nih.gov/pubmed/30599058 http://dx.doi.org/10.1007/s10654-018-0475-8 |
_version_ | 1783409204791345152 |
---|---|
author | Huth, Cornelia von Toerne, Christine Schederecker, Florian de las Heras Gala, Tonia Herder, Christian Kronenberg, Florian Meisinger, Christa Rathmann, Wolfgang Koenig, Wolfgang Waldenberger, Melanie Roden, Michael Peters, Annette Hauck, Stefanie M. Thorand, Barbara |
author_facet | Huth, Cornelia von Toerne, Christine Schederecker, Florian de las Heras Gala, Tonia Herder, Christian Kronenberg, Florian Meisinger, Christa Rathmann, Wolfgang Koenig, Wolfgang Waldenberger, Melanie Roden, Michael Peters, Annette Hauck, Stefanie M. Thorand, Barbara |
author_sort | Huth, Cornelia |
collection | PubMed |
description | The objective of the present study was to identify proteins that contribute to pathophysiology and allow prediction of incident type 2 diabetes or incident prediabetes. We quantified 14 candidate proteins using targeted mass spectrometry in plasma samples of the prospective, population-based German KORA F4/FF4 study (6.5-year follow-up). 892 participants aged 42–81 years were selected using a case-cohort design, including 123 persons with incident type 2 diabetes and 255 persons with incident WHO-defined prediabetes. Prospective associations between protein levels and diabetes, prediabetes as well as continuous fasting and 2 h glucose, fasting insulin and insulin resistance were investigated using regression models adjusted for established risk factors. The best predictive panel of proteins on top of a non-invasive risk factor model or on top of HbA1c, age, and sex was selected. Mannan-binding lectin serine peptidase (MASP) levels were positively associated with both incident type 2 diabetes and prediabetes. Adiponectin was inversely associated with incident type 2 diabetes. MASP, adiponectin, apolipoprotein A-IV, apolipoprotein C-II, C-reactive protein, and glycosylphosphatidylinositol specific phospholipase D1 were associated with individual continuous outcomes. The combination of MASP, apolipoprotein E (apoE) and adiponectin improved diabetes prediction on top of both reference models, while prediabetes prediction was improved by MASP plus CRP on top of the HbA1c model. In conclusion, our mass spectrometric approach revealed a novel association of MASP with incident type 2 diabetes and incident prediabetes. In combination, MASP, adiponectin and apoE improved type 2 diabetes prediction beyond non-invasive risk factors or HbA1c, age and sex. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s10654-018-0475-8) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-6451724 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Springer Netherlands |
record_format | MEDLINE/PubMed |
spelling | pubmed-64517242019-04-17 Protein markers and risk of type 2 diabetes and prediabetes: a targeted proteomics approach in the KORA F4/FF4 study Huth, Cornelia von Toerne, Christine Schederecker, Florian de las Heras Gala, Tonia Herder, Christian Kronenberg, Florian Meisinger, Christa Rathmann, Wolfgang Koenig, Wolfgang Waldenberger, Melanie Roden, Michael Peters, Annette Hauck, Stefanie M. Thorand, Barbara Eur J Epidemiol Diabetes Mellitus The objective of the present study was to identify proteins that contribute to pathophysiology and allow prediction of incident type 2 diabetes or incident prediabetes. We quantified 14 candidate proteins using targeted mass spectrometry in plasma samples of the prospective, population-based German KORA F4/FF4 study (6.5-year follow-up). 892 participants aged 42–81 years were selected using a case-cohort design, including 123 persons with incident type 2 diabetes and 255 persons with incident WHO-defined prediabetes. Prospective associations between protein levels and diabetes, prediabetes as well as continuous fasting and 2 h glucose, fasting insulin and insulin resistance were investigated using regression models adjusted for established risk factors. The best predictive panel of proteins on top of a non-invasive risk factor model or on top of HbA1c, age, and sex was selected. Mannan-binding lectin serine peptidase (MASP) levels were positively associated with both incident type 2 diabetes and prediabetes. Adiponectin was inversely associated with incident type 2 diabetes. MASP, adiponectin, apolipoprotein A-IV, apolipoprotein C-II, C-reactive protein, and glycosylphosphatidylinositol specific phospholipase D1 were associated with individual continuous outcomes. The combination of MASP, apolipoprotein E (apoE) and adiponectin improved diabetes prediction on top of both reference models, while prediabetes prediction was improved by MASP plus CRP on top of the HbA1c model. In conclusion, our mass spectrometric approach revealed a novel association of MASP with incident type 2 diabetes and incident prediabetes. In combination, MASP, adiponectin and apoE improved type 2 diabetes prediction beyond non-invasive risk factors or HbA1c, age and sex. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s10654-018-0475-8) contains supplementary material, which is available to authorized users. Springer Netherlands 2018-12-31 2019 /pmc/articles/PMC6451724/ /pubmed/30599058 http://dx.doi.org/10.1007/s10654-018-0475-8 Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Diabetes Mellitus Huth, Cornelia von Toerne, Christine Schederecker, Florian de las Heras Gala, Tonia Herder, Christian Kronenberg, Florian Meisinger, Christa Rathmann, Wolfgang Koenig, Wolfgang Waldenberger, Melanie Roden, Michael Peters, Annette Hauck, Stefanie M. Thorand, Barbara Protein markers and risk of type 2 diabetes and prediabetes: a targeted proteomics approach in the KORA F4/FF4 study |
title | Protein markers and risk of type 2 diabetes and prediabetes: a targeted proteomics approach in the KORA F4/FF4 study |
title_full | Protein markers and risk of type 2 diabetes and prediabetes: a targeted proteomics approach in the KORA F4/FF4 study |
title_fullStr | Protein markers and risk of type 2 diabetes and prediabetes: a targeted proteomics approach in the KORA F4/FF4 study |
title_full_unstemmed | Protein markers and risk of type 2 diabetes and prediabetes: a targeted proteomics approach in the KORA F4/FF4 study |
title_short | Protein markers and risk of type 2 diabetes and prediabetes: a targeted proteomics approach in the KORA F4/FF4 study |
title_sort | protein markers and risk of type 2 diabetes and prediabetes: a targeted proteomics approach in the kora f4/ff4 study |
topic | Diabetes Mellitus |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6451724/ https://www.ncbi.nlm.nih.gov/pubmed/30599058 http://dx.doi.org/10.1007/s10654-018-0475-8 |
work_keys_str_mv | AT huthcornelia proteinmarkersandriskoftype2diabetesandprediabetesatargetedproteomicsapproachinthekoraf4ff4study AT vontoernechristine proteinmarkersandriskoftype2diabetesandprediabetesatargetedproteomicsapproachinthekoraf4ff4study AT schedereckerflorian proteinmarkersandriskoftype2diabetesandprediabetesatargetedproteomicsapproachinthekoraf4ff4study AT delasherasgalatonia proteinmarkersandriskoftype2diabetesandprediabetesatargetedproteomicsapproachinthekoraf4ff4study AT herderchristian proteinmarkersandriskoftype2diabetesandprediabetesatargetedproteomicsapproachinthekoraf4ff4study AT kronenbergflorian proteinmarkersandriskoftype2diabetesandprediabetesatargetedproteomicsapproachinthekoraf4ff4study AT meisingerchrista proteinmarkersandriskoftype2diabetesandprediabetesatargetedproteomicsapproachinthekoraf4ff4study AT rathmannwolfgang proteinmarkersandriskoftype2diabetesandprediabetesatargetedproteomicsapproachinthekoraf4ff4study AT koenigwolfgang proteinmarkersandriskoftype2diabetesandprediabetesatargetedproteomicsapproachinthekoraf4ff4study AT waldenbergermelanie proteinmarkersandriskoftype2diabetesandprediabetesatargetedproteomicsapproachinthekoraf4ff4study AT rodenmichael proteinmarkersandriskoftype2diabetesandprediabetesatargetedproteomicsapproachinthekoraf4ff4study AT petersannette proteinmarkersandriskoftype2diabetesandprediabetesatargetedproteomicsapproachinthekoraf4ff4study AT hauckstefaniem proteinmarkersandriskoftype2diabetesandprediabetesatargetedproteomicsapproachinthekoraf4ff4study AT thorandbarbara proteinmarkersandriskoftype2diabetesandprediabetesatargetedproteomicsapproachinthekoraf4ff4study |